Key result
High serum triglycerides were associated with mildly but non-significantly elevated risks of cardiovascular mortality relative to the middle level of serum triglycerides (P=0.35).
Why the study?
The relationship between serum triglycerides and all-cause, cardiovascular, and non-cardiovascular mortality in elderly Chinese populations required investigation.
Does serum triglyceride concentration affect all-cause and cardiovascular mortality in an elderly Chinese population?
Observational (n=3,565)
No
Does serum triglyceride concentration affect all-cause and cardiovascular mortality in an elderly Chinese population?
p-value: p=0.35
In an elderly Chinese cohort, hypertriglyceridemia was highly prevalent but only non-significantly associated with elevated cardiovascular mortality.
Should not alter triglyceride management in elderly Chinese patients; leaves open their prognostic role for cardiovascular mortality.
OBJECTIVE: To investigate serum triglycerides in relation to all-cause, cardiovascular, and non-cardiovascular mortality in an elderly Chinese population. METHODS: = 3565) were elderly (≥ 60 years) community dwellers living in a suburban town of Shanghai. Hypertriglyceridemia was defined as a serum triglycerides concentration ≥ 2.30 mmol/L (definite) and ≥ 1.70 mmol/L (borderline), respectively. RESULTS: = 0.35) for all-cause, cardiovascular and non-cardiovascular mortality, respectively. CONCLUSIONS: Our study showed high prevalence of hypertriglyceridemia, especially when defined as borderline and in obese and overweight participants, and mildly but non-significantly elevated risks of cardiovascular mortality relative to the middle level of serum triglycerides.
No takes yet. Share an insight, caveat, or question.
Miao et al. (2022) reported an observational. Serum triglycerides concentration vs. Middle level of serum triglycerides was evaluated on All-cause, cardiovascular, and non-cardiovascular mortality (p=0.35). High serum triglycerides were associated with mildly but non-significantly elevated risks of cardiovascular mortality relative to the middle level of serum triglycerides (P=0.35).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: